Prednisone use is linked to pneumonia risk in patients with rheumatoid arthritis
Chrissie Giles
This article has no abstract so we have provided the first paragraph of the full text.
Infectious pneumonia is a major cause of death in patients with rheumatoid arthritis (RA), but this relationship has not been specifically studied. Wolfe et al. aimed to find the incidence of pneumonia among these patients, and to determine if treatment with prednisone, disease-modifying antirheumatic drugs, or anti-tumor necrosis factor (anti-TNF) agents increases the risk of pneumonia. The team assessed 16,788 patients with RA from the National Data Bank for Rheumatic Diseases, every 6 months for 3.5 years.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
